Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Efficacy of Rapid-Acting NMDA Antagonist for Treatment of Adolescent Depression and Anxiety Disorders


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02579928

Organisation Name: Yale University

Overal Status: Completed

Start Date: October 2015

Last Update: July 14, 2020

Lead Sponsor: Yale University

Brief Summary: The purpose of this study is to determine the tolerability and short-term efficacy of a single ketamine infusion for the treatment of adolescents with 1) medication-refractory major depressive disorder (MDD) and/or 2) medication-refractory anxiety disorders (social anxiety disorder, panic disorder, generalized anxiety disorder and/or separation anxiety disorder).

Conditions:
  • Major Depressive Disorder
  • Anxiety Disorder


Total execution time in seconds: 0.27167201042175